Targeted EosFP mutations at residues 41, 70, and 197 raise photoconversion contrast and cut photoblinking for more precise single-molecule imaging.
A truncated triple-splice dystrophin rAAV composition fits AAV cargo limits while reducing immune response and improving muscle function.
Engineered rAAV vectors boost Factor H expression while lowering immunogenicity for treating Factor H deficiency disorders.
Synthetic BP180 and BP230 peptide epitopes replace complex recombinant proteins for sensitive bullous pemphigoid autoantibody detection.
Modular CRISPR-Cas components expand programmable DNA and RNA editing while keeping effector complexity manageable for genome and epigenome work.